Genome Network (GNOME): tokenomics, risks and score
A network for individuals to sequence, own and monetise their genomic data, with researchers paying for access to consented datasets.
What Genome Network is, and what it does
This is a DePIN network. It pays people to supply real physical infrastructure such as wireless coverage, sensors, storage or mapping, and sells the resulting service or data.
What the GNOME token itself does: Fees are used to buy and destroy the token, so usage of the protocol permanently reduces the supply.
Where it runs: Multi chain. Mechanism: Genomic data network. It has been running since 2024, so roughly 2 years.
The facts
- TICKER
- GNOME
- SECTOR
- DePIN
- CHAIN
- Multi chain
- LAUNCHED
- 2024, so around 2 years of operating history
- MECHANISM
- Genomic data network
- MAXIMUM SUPPLY
- Not consistently documented
- VALUE CAPTURE
- Buyback burn
- UPGRADE CONTROL
- Team controlled
- VESTING
- Not published
- LIQUIDITY BAND
- Micro cap. Thin, often a single venue or pool. Treat the quoted price as indicative only.
How the score breaks down
Each dimension is explained on the directory page, and the reasoning behind it is taught in the Academy research process.
Supply and value capture
A hard maximum supply that cannot be raised without the agreement of essentially every participant. Fees are used to buy and destroy supply, so usage reduces the number of tokens outstanding.
The founding team retains control over upgrades or parameters. Ownership is heavily concentrated. A small number of wallets hold enough to determine the price on their own.
Where it is strong and where it is not
- Supply is capped, so holders are not diluted indefinitely
- The token captures real protocol revenue rather than relying on speculation alone
- Heavily concentrated ownership means a few wallets control the outcome
- Upgrade control sits with a small group, so the rules can change
- Thin liquidity. Check order book depth before assuming you can exit
- Short operating history, so it has not yet been tested by a full market cycle
Incident history
No major exploit, collapse or regulatory action on record against this asset.
Our read
The main risk
Severe health data regulation, and supply and vesting details are not consistently documented.
Before you buy anything
Check the contract address against the project's own documentation rather than a search result or a screener link, since impersonation tokens with identical names and logos are listed constantly. Check the order book depth before assuming you can exit at the quoted price. And write down what would make you wrong before you buy, not after. The Academy thesis module covers why that single habit protects more capital than any indicator.